Full Text View
Tabular View
No Study Results Posted
Related Studies
Moxifloxacin for the Treatment of Acute Exacerbation of Chronic Bronchitis
This study is currently recruiting participants.
Study NCT00656747   Information provided by Bayer
First Received: April 4, 2008   Last Updated: September 30, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Chronic Bronchitis
Additional conditions recognized in this trial
Acute Disease
Bronchitis
Bronchitis, Chronic
More general conditions related to this trial
Bronchial Diseases
Disease Attributes
Lung Diseases
Lung Diseases, Obstructive
Pathologic Processes
Pulmonary Disease, Chronic Obstructive
Respiratory Tract Diseases
Respiratory Tract Infections
Interventions listed in this trial
Avelox (Moxifloxacin, BAY12-8039)
Amoxicillin
Additional drug interventions recognized in this trial
Amoxicillin-Potassium Clavulanate Combination
Clavulanic Acid
Clavulanic Acids
Moxifloxacin
More general drug interventions related to this trial
Anti-Bacterial Agents
Anti-Infective Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Bayer


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services